Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$75,453,008
+$32,658,203 QoQ
Shares Held
4,118,614
+55.7% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#17
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. ERAS ranks #20 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,453,008 | 4,118,614 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $42,794,805 | 2,644,920 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $776,773 | 208,810 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $508,877 | 233,430 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $296,456 | 233,430 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $211,651 | 154,490 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $387,769 | 154,490 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $421,757 | 154,490 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $364,596 | 154,490 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $243,718 | 118,310 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $252,000 | 118,310 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $233,070 | 118,310 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $309,644 | 112,190 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $586,016 | 194,690 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,598,299 | 1,994,965 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $32,316,367 | 4,143,124 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $22,646,667 | 4,065,829 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $29,186,086 | 3,393,731 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $50,738,544 | 3,256,646 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $53,623,597 | 2,527,031 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||